Brückner, M.; Fichter, M.; da Costa Marques, R.; Landfester, K.; Mailänder, V.
PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets. Pharmaceutics 2022, 14, 1614.
https://doi.org/10.3390/pharmaceutics14081614
AMA Style
Brückner M, Fichter M, da Costa Marques R, Landfester K, Mailänder V.
PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets. Pharmaceutics. 2022; 14(8):1614.
https://doi.org/10.3390/pharmaceutics14081614
Chicago/Turabian Style
Brückner, Maximilian, Michael Fichter, Richard da Costa Marques, Katharina Landfester, and Volker Mailänder.
2022. "PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets" Pharmaceutics 14, no. 8: 1614.
https://doi.org/10.3390/pharmaceutics14081614
APA Style
Brückner, M., Fichter, M., da Costa Marques, R., Landfester, K., & Mailänder, V.
(2022). PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets. Pharmaceutics, 14(8), 1614.
https://doi.org/10.3390/pharmaceutics14081614